Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $243.08 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $69.45 | 4 | $0 (2023) |
| Keryx Biopharmaceuticals, Inc. | $43.43 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $37.79 | 2 | $0 (2024) |
| Novo Nordisk Inc | $21.87 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $18.31 | 1 | $0 (2023) |
| Daiichi Sankyo Inc. | $18.15 | 1 | $0 (2017) |
| Shield Therapeutics Inc | $17.29 | 1 | $0 (2023) |
| OPKO Pharmaceuticals, LLC | $16.79 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59.66 | 3 | GlaxoSmithKline, LLC. ($37.79) |
| 2023 | $105.05 | 6 | Lilly USA, LLC ($69.45) |
| 2018 | $23.49 | 1 | Keryx Biopharmaceuticals, Inc. ($23.49) |
| 2017 | $54.88 | 3 | Keryx Biopharmaceuticals, Inc. ($19.94) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: VACCINES | ||||||
| 06/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: VACCINES | ||||||
| 04/27/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Diabetes | ||||||
| 04/13/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Hematology | ||||||
| 04/07/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Neuroscience | ||||||
| 03/16/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Diabetes | ||||||
| 03/16/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Diabetes | ||||||
| 03/20/2018 | Keryx Biopharmaceuticals, Inc. | Auryxia (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Nephrology | ||||||
| 12/05/2017 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Anemia | ||||||
| 10/18/2017 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Hyperparathyroidism | ||||||
| 07/10/2017 | Keryx Biopharmaceuticals, Inc. | Auryxia (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,129 | 1,306 | $158,065 | $51,864 |
| 2022 | 5 | 111 | 114 | $14,452 | $5,432 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 213 | $55,806 | $18,559 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 211 | 244 | $43,188 | $11,643 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $17,600 | $4,739 | 26.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 33 | $11,649 | $3,874 | 33.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 29 | 29 | $8,265 | $3,542 | 42.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $6,048 | $1,839 | 30.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 81 | 96 | $2,016 | $1,260 | 62.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 59 | 68 | $1,768 | $1,119 | 63.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 70 | 80 | $2,800 | $828.00 | 29.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 67 | 84 | $1,092 | $696.36 | 63.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 57 | $1,710 | $542.64 | 31.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 16 | 18 | $828.00 | $493.17 | 59.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 58 | 62 | $744.00 | $464.21 | 62.4% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 66 | 68 | $680.00 | $424.78 | 62.5% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 17 | 17 | $476.00 | $321.64 | 67.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 17 | 17 | $748.00 | $294.27 | 39.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 14 | 14 | $616.00 | $242.34 | 39.3% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 18 | 22 | $308.00 | $194.48 | 63.1% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 12 | 13 | $273.00 | $173.68 | 63.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 16 | $656.00 | $161.14 | 24.6% |
| 80076 | Liver function blood test panel | Office | 2023 | 11 | 14 | $182.00 | $112.14 | 61.6% |
| 83550 | Iron binding capacity | Office | 2023 | 11 | 12 | $156.00 | $102.84 | 65.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 29 | 30 | $150.00 | $93.30 | 62.2% |
| 83540 | Iron level | Office | 2023 | 11 | 12 | $120.00 | $76.08 | 63.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 31 | 31 | $186.00 | $68.20 | 36.7% |
About Dr. Christopher Buehrig, MD
Dr. Christopher Buehrig, MD is a Nephrology healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346206927.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Buehrig, MD has received a total of $243.08 in payments from pharmaceutical and medical device companies, with $59.66 received in 2024. These payments were reported across 13 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($243.08).
As a Medicare-enrolled provider, Buehrig has provided services to 1,240 Medicare beneficiaries, totaling 1,420 services with total Medicare billing of $57,296. Data is available for 2 years (2022–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology, Internal Medicine
- Location Charlotte, NC
- Active Since 04/24/2006
- Last Updated 09/13/2022
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1346206927
Products in Payments
- Auryxia (Drug) $43.43
- SHINGRIX (Biological) $37.79
- JARDIANCE (Drug) $34.58
- Rybelsus (Drug) $21.87
- MOUNJARO (Drug) $18.48
- BELSOMRA (Drug) $18.31
- INJECTAFER (Drug) $18.15
- ACCRUFER (Drug) $17.29
- Rayaldee (Drug) $16.79
- EMGALITY (Drug) $16.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Charlotte
Dr. Michael Etomi, Md, MD
Nephrology — Payments: $258,807
Matthew Elliott, Md, MD
Nephrology — Payments: $31,303
George Hart, Md, MD
Nephrology — Payments: $5,831
Dr. Peale Chuang, M.d, M.D
Nephrology — Payments: $5,436
Ms. Kathleen Doman, M.d, M.D
Nephrology — Payments: $4,654
Dr. Verachai Lohavichan, M.d, M.D
Nephrology — Payments: $4,195